This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieTeaching Note HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Starting at €0.00
-
THE YES: Reimagining the Future of E-Commerce with Artificial Intelligence (AI)
Avery, Jill; Israeli, Ayelet; von Maur, EmmaCase HBS-521070-EMarketingTHE YES, a multi-brand shopping app launched in May 2020 offered a new type of buying experience for women's fashion, driven by a sophisticated algorithm that used data science and machine learning to create and deliver a personalized store for every shopper, based on her style preferences, size, and budget. When a woman downloaded THE YES app, she embarked upon an interactive shopping journey that leveraged a fun, easy, gamified user experience ...Starting at €8.20
-
THE YES: Reimagining the Future of E-Commerce with Artificial Intelligence (AI), Teaching Note
Israeli, Ayelet; Avery, JillTeaching Note HBS-521097-EMarketingTeaching note for case 521070.Starting at €0.00
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Case HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Away: Scaling a DTC Travel Brand
Avery, Jill; Fuller, Joseph B.Case HBS-520051-EMarketingAway, a direct-to-consumer, digital native e-commerce seller of travel luggage, is debating how to invest its latest round of venture funding. How quickly could and should Away scale and what were the most promising growth trajectories to maximize its potential? Three decisions face the founders. Should Away continue to invest in driving growth in suitcases and other travel bags or was it time to begin to expand into other adjacent travel categor...Starting at €8.20
-
Hubble Contact Lenses: Data Driven Direct-to-Consumer Marketing
Avery, Jill; Israeli, AyeletCase HBS-519011-EMarketingThe Inside the Case video that accompanies this case includes teaching tips and insight from the author (available to registered educators only). As its Series A extension round approaches, the founders of Hubble, a subscription-based, social-media fueled, direct-to-consumer (DTC) brand of contact lenses, are reflecting on the marketing strategies that have taken them to a valuation of $200 million and debating changes to them that will allow th...Starting at €8.20
-
J.C. Penney's 'Fair and Square' Strategy (B): Out with the New, In with the Old
Ofek, Elie; Avery, Jill; Alvarez, Jose B.Case HBS-514085-EMarketingIn his August 2012 earnings call, CEO Ron Johnson urged investors to be patient and stay the course with the revised JC Penney marketing strategy despite mounting negative financial indicators. The heart of the strategy was the "Fair and Square" approach to pricing. This was a switch from J.C. Penney's previous high-low pricing program to a new everyday low pricing policy that aimed to fit with a radical repositioning of the JC Penney business mo...Starting at €5.74
-
Relating to Peapod, Teaching Note
Avery, Jill; Fournier, SusanTeaching Note HBS-316175-EMarketingTeaching note for case 314142.Starting at €0.00
-
J.C. Penney's 'Fair and Square' Strategy (C): Back to the Future
Ofek, Elie; Avery, Jill; Alvarez, Jose B.Case HBS-514073-EMarketingRehired in April 2013, Myron E. "Mike" Ullman III was brought back to stabilize the retailer's business. Under Ron Johnson's "Fair and Square" program, sales had declined rapidly and quarterly losses and expensive capital investments had put severe pressure on cash reserves. Ullman decided to combine "Fair and Square" everyday low pricing and high/low pricing to reverse the negative trend. For example, to welcome people back to its stores, J.C. P...Starting at €5.74